191 related articles for article (PubMed ID: 35013909)
1. Evaluation of a blood-based geroscience biomarker index in a randomized trial of caloric restriction and exercise in older adults with heart failure with preserved ejection fraction.
Justice JN; Pajewski NM; Espeland MA; Brubaker P; Houston DK; Marcovina S; Nicklas BJ; Kritchevsky SB; Kitzman DW
Geroscience; 2022 Apr; 44(2):983-995. PubMed ID: 35013909
[TBL] [Abstract][Full Text] [Related]
2. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Kitzman DW; Brubaker P; Morgan T; Haykowsky M; Hundley G; Kraus WE; Eggebeen J; Nicklas BJ
JAMA; 2016 Jan; 315(1):36-46. PubMed ID: 26746456
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
Reddy YNV; Lewis GD; Shah SJ; Obokata M; Abou-Ezzedine OF; Fudim M; Sun JL; Chakraborty H; McNulty S; LeWinter MM; Mann DL; Stevenson LW; Redfield MM; Borlaug BA
Mayo Clin Proc; 2019 Jul; 94(7):1199-1209. PubMed ID: 31272568
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction.
Brubaker PH; Nicklas BJ; Houston DK; Hundley WG; Chen H; Molina AJA; Lyles WM; Nelson B; Upadhya B; Newland R; Kitzman DW
Circ Heart Fail; 2023 Feb; 16(2):e010161. PubMed ID: 36314122
[TBL] [Abstract][Full Text] [Related]
6. Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction.
Haykowsky MJ; Nicklas BJ; Brubaker PH; Hundley WG; Brinkley TE; Upadhya B; Becton JT; Nelson MD; Chen H; Kitzman DW
JACC Heart Fail; 2018 Aug; 6(8):640-649. PubMed ID: 30007558
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
[TBL] [Abstract][Full Text] [Related]
8. Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Shah SJ; Voors AA; McMurray JJV; Kitzman DW; Viethen T; Bomfim Wirtz A; Huang E; Pap AF; Solomon SD
JAMA; 2019 Jun; 321(21):2101-2112. PubMed ID: 31162568
[TBL] [Abstract][Full Text] [Related]
9. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
10. The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical Function, and Patient-Reported Outcomes in Adults With Preserved Ejection Fraction Heart Failure.
Alonso WW; Kupzyk KA; Norman JF; Lundgren SW; Fisher A; Lindsey ML; Keteyian SJ; Pozehl BJ
J Card Fail; 2022 Mar; 28(3):431-442. PubMed ID: 34534664
[TBL] [Abstract][Full Text] [Related]
11. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
[TBL] [Abstract][Full Text] [Related]
12. Physiological dead space during exercise in patients with heart failure with preserved ejection fraction.
Balmain BN; Tomlinson AR; MacNamara JP; Sarma S; Levine BD; Hynan LS; Babb TG
J Appl Physiol (1985); 2022 Mar; 132(3):632-640. PubMed ID: 35112932
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
[TBL] [Abstract][Full Text] [Related]
14. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
[TBL] [Abstract][Full Text] [Related]
15. Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
Udelson JE; Lewis GD; Shah SJ; Zile MR; Redfield MM; Burnett J; Parker J; Seferovic JP; Wilson P; Mittleman RS; Profy AT; Konstam MA
JAMA; 2020 Oct; 324(15):1522-1531. PubMed ID: 33079154
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
17. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
[TBL] [Abstract][Full Text] [Related]
18. Effects of Caloric Restriction on Cardiorespiratory Fitness, Fatigue, and Disability Responses to Aerobic Exercise in Older Adults With Obesity: A Randomized Controlled Trial.
Nicklas BJ; Brinkley TE; Houston DK; Lyles MF; Hugenschmidt CE; Beavers KM; Leng X
J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1084-1090. PubMed ID: 29982294
[TBL] [Abstract][Full Text] [Related]
19. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on the regulation of muscle blood flow during exercise in patients with heart failure with a preserved ejection fraction.
Ratchford SM; Lee JF; Bunsawat K; Alpenglow JK; Zhao J; Ma CL; Ryan JJ; Khor LL; Wray DW
J Appl Physiol (1985); 2022 May; 132(5):1240-1249. PubMed ID: 35421322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
